Výsledky vyhledávání

Akademický článek

Effect of early shearing during gestation on the productive and reproductive behavior of female sheep offspring in their first 18 months of age

Autor: C. López-Mazz, F. Baldi, G. Quintans, P.R. Kenyon, O. Correa, M. Regueiro, A. Álvarez-Oxiley, G.E. Banchero

Publikováno v: Animal, Vol 14, Iss 4, Pp 807-813 (2020)

The research has shown the interesting contributions of shearing in mid-gestation on the performance of lambs from birth to weaning. Other studies have reported that shearing at early pregnancy influences the development of the placenta and lamb live

Externí odkaz: https://doaj.org/article/acd6a557cd154e0cbb262e8c0cbf9bd2

Zobrazit plný text záznamu

Akademický článek

Mármoles romanos y canteras en Talavera de la Reina

Autor: Dionisio URBINA, Alejandro SÁNCHEZ, Manuel LOMBARDERO, M. REGUEIRO

Publikováno v: Zephyrus, Vol 50, Iss 0 (2009)

RESUMEN: El presente trabajo tiene como objetivo la localización de las canteras donde fue extraído el mármol hallado en las excavaciones de la Ronda del Canillo 16, Talavera de la Reina. Sobre la base de la diversidad geológica de la zona, parec

Externí odkaz: https://doaj.org/article/ba509dd06ab0467fa95c5720be38770d

Zobrazit plný text záznamu

Akademický článek

Latin America and the Caribbean within the new world order: a perspective from Cuba

Autor: Claudia Marín Suárez, Lourdes M. Regueiro Bello

Publikováno v: Ибероамериканские тетради, Vol 8, Iss 4, Pp 65-78 (2021)

In examining Cuba’s positioning in Latin America and the Caribbean and in the world at large, the author identifies several relevant factors, including the US foreign policy, the Venezuela issue, as well as the balance of political power in the reg

Externí odkaz: https://doaj.org/article/e165e9da4367457ebd318bb1eddbf332

Zobrazit plný text záznamu

P476 Characterization of cardiac conduction abnormalities reported in the phase 3 ELEVATE programme

Autor: S Vermeire, A Yarur, D T Rubin, M C Dubinsky, M Regueiro, P Irving, L Peyrin-Biroulet, M Goetsch, G Gu, J Wu, I Modesto, A McDonnell, C J Rabbat, J Green, P Anthopoulos

Publikováno v: Journal of Crohn's and Colitis. 17:i604-i606

Background Etrasimod is an investigational, once-daily, oral, selective sphingosine 1-phosphate receptor 1,4,5 (S1P1,4,5) modulator in development for the treatment of moderately to severely active ulcerative colitis (UC). First-dose, transient heart

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c8768b89687d99822c0ca2750202ae32
https://doi.org/10.1093/ecco-jcc/jjac190.0606

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

DOP39 Endoscopic, histologic, and combined outcomes with reinitiation of ozanimod after temporary discontinuation: 2-year interim analysis of the True North open-label extension study

Autor: S Vermeire, A Dignass, J F Colombel, A Jain, J B Canavan, H Wu, G Lawlor, M T Osterman, D T Rubin, M Regueiro

Publikováno v: Journal of Crohn's and Colitis. 17:i103-i104

Background Mucosal healing, evaluated by a combination of endoscopic and histologic examinations, is a desired outcome in ulcerative colitis (UC), but few long-term or open-label extension (OLE) studies of UC treatments have assessed these outcomes.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68bb3a7836beee71210936fa40f19f71
https://doi.org/10.1093/ecco-jcc/jjac190.0079

Zobrazit plný text záznamu

DOP38 Upadacitinib Therapy Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy

Autor: J F Colombel, T Hisamatsu, F Bresso, L Thin, R Parra, S Ford, V Remple, A P Lacerda, P Hecht, M Mallick, A Garrison, M Regueiro

Publikováno v: Journal of Crohn's and Colitis. 17:i102-i103

Background Upadacitinib (UPA), an oral, selective JAK inhibitor demonstrated superior efficacy for clinical remission compared with placebo (PBO) and an acceptable safety profile in patients with moderately to severely active Crohn’s disease (CD) i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a7ca7cbd0f41d3479dc585b5009d763
https://doi.org/10.1093/ecco-jcc/jjac190.0078

Zobrazit plný text záznamu

DOP43 Extended induction in the True North OLE study: ozanimod efficacy in biologic-naive and biologic-experienced patients

Autor: A Dignass, M Regueiro, J F Colombel, A Jain, J B Canavan, H Wu, G Lawlor, M T Osterman, S Vermeire, D T Rubin

Publikováno v: Journal of Crohn's and Colitis. 17:i110-i111

Background Prior exposure to biologics can influence response to subsequent lines of advanced therapies. Previous analyses showed that patients who did not achieve clinical response following 10 weeks of ozanimod treatment in the phase 3 True North (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9cbedb1998b2befc195e141364c75f46
https://doi.org/10.1093/ecco-jcc/jjac190.0083

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání